Table 1.
Patient characteristics before discharge
| All (n=192) |
All-cause mortality or | P value (– vs +) |
||
| Admission for heart failure | ||||
| – (n=142) | + (n=50) | |||
| Age, years | 80.0±10.0 | 78.9±10.1 | 83.1±9.1 | 0.011 |
| Male sex, n (%) | 79 (41) | 59 (42) | 20 (40) | 0.848 |
| Cardiothoracic ratio, % | 55.4±7.5 | 54.8±7.4 | 57.2±7.7 | 0.093 |
| Systolic blood pressure, mm Hg | 122±18 | 120±17 | 124±21 | 0.078 |
| Diastolic blood pressure, mm Hg | 64±12 | 65±12 | 62±11 | 0.212 |
| Heart rate, beats/min | 69±14 | 69±14 | 68±12 | 0.576 |
| Chronic obstructive pulmonary disease, n (%) | 11 (6) | 9 (7) | 2 (4) | 0.796 |
| Coronary artery disease, n (%) | 41 (21) | 31 (22) | 10 (20) | 0.785 |
| Diabetes mellitus, n (%) | 73 (38) | 48 (34) | 25 (50) | 0.043 |
| Dyslipidaemia, n (%) | 92 (48) | 65 (46) | 27 (54) | 0.316 |
| Hypertension, n (%) | 169 (88) | 121 (85) | 48 (96) | 0.077 |
| Laboratory data | ||||
| Haemoglobin, g/L | 1.10±0.18 | 1.11±0.18 | 1.05±0.19 | 0.062 |
| Albumin, g/dL | 3.3±0.5 | 3.4±0.5 | 3.1±0.6 | <0.001 |
| eGFR, mL/min/1.73 m2 | 42.3±22.1 | 44.4±21.7 | 36.3±22.6 | 0.026 |
| N-terminal pro-brain natriuretic peptide, pg/mL | 2971±8478 | 2096±4832 | 5557±14 490 | 0.017 |
| Medications | ||||
| Beta-blockers, n (%) | 109 (57) | 82 (58) | 27 (54) | 0.645 |
| Calcium-channel blockers, n (%) | 112 (58) | 80 (56) | 32 (64) | 0.344 |
| Diuretics, n (%) | 146 (76) | 105 (74) | 41 (82) | 0.251 |
| RAAS inhibitors, n (%) | 133 (69) | 94 (66) | 39 (78) | 0.119 |
| Statins, n (%) | 72 (38) | 50 (35) | 22 (44) | 0.269 |
Values are mean±SD or number (%).
eGFR, estimated glomerular filtration rate; RAAS, renin-angiotensin-aldosterone system.